Postmarketing adverse events of tamoxifen in male and female patients with breast cancer. Ke C, Chen M, Lin L, Huang Y, et al. Int J Cancer 2024 Sep 21. doi: 10.1002/ijc.35193.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ke C, Chen M, Lin L, Huang Y, et al. Postmarketing adverse events of tamoxifen in male and female patients with breast cancer. Int J Cancer 2024 Sep 21. doi: 10.1002/ijc.35193.
PMID: 39305475